Search Results 881-890 of 18081 for Alopecia

  1. Getting pregnant Fertility - Mayo Clinic

    Learn about fertility, parental health and pregnancy symptoms.

  2. A Clinical Evaluation of Semen Quality Using the MiOXSYS™ System 2.0

    About this study. The purpose of this study is to determine if elevations in oxidative stress, as measured by oxidation-reduction potential (ORP), ...

  3. A Study To Evaluate The Effect Of Motion And Poor Circulation On Various Pulse Oximeter Performances During Heart Failure Stress Tests - Mayo Clinic

    The purpose of this study is to compare pulse oximetry performances from different manufacturers and with different anatomical sensor locations during stress ...

  4. Combination Study of SV-BR-1-GM in Combination With INCMGA00012 and Retifanlimab - Mayo Clinic

    Toxicity of prior therapy that has not recovered to ≤ Grade 1 or baseline (with the exception of any grade of alopecia and anemia not requiring transfusion ...

  5. Hereditary hemorrhagic telangiectasia - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  6. Mayo Clinic

    National Doctors' Day is March 30! Give Now! Your gift to celebrate this day advances our doctors' lifesaving work. Give Now!

  7. Oral AMXT 1501 Dicaprate in Combination With IV DFMO - Mayo Clinic

    ... alopecia, etc.). Patients who have an ongoing requirement for thyroid replacement therapy from prior exposure to a checkpoint inhibitor but who are ...

  8. A Study to Describe Patterns of Treatment, Demographics, Clinical Characteristics, and Overall Survival in Patients with Unresectable or Metastatic Melanoma

    A Study to Describe Patterns of Treatment, Demographics, Clinical Characteristics, and Overall Survival in Patients with Unresectable or Metastatic Melanoma.

  9. A Study of Catequentinib, Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma - Mayo Clinic

    Any unrecovered toxicity reactions of CTCAE version 4.03 ≥ grade 1 caused by any previous therapy (excluding alopecia and neurotoxicity ≤ grade 2). QTcF ...

  10. Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer - Mayo Clinic

    The purpose of this study is to explore the detection of circulating tumor DNA, soluble immune markers, and the evaluation of peripheral blood mononuclear cells ...